Top 10 Companies in the Trehalose Market (2026): Market Leaders Shaping the Future of Functional Ingredients

MARKET INSIGHTS

Global trehalose market size was valued at USD 186 million in 2025 and is projected to grow from USD 199 million in 2026 to USD 318 million by 2034, exhibiting a CAGR of 6.7% during the forecast period.

Trehalose (C₁₂H₂₂O₁₁) is a naturally occurring non‑reducing disaccharide that serves as a multifunctional ingredient across industries. This stable sugar derivative demonstrates exceptional properties including water retention, cryoprotection, and thermal stability, making it indispensable in food preservation and biopharmaceutical formulations. While it maintains only 45% of sucrose’s sweetness intensity, its superior functional benefits have driven adoption as a premium sugar substitute in processed foods and functional beverages.

Market growth is primarily propelled by expanding applications in frozen desserts and bakery products where trehalose prevents crystallization and extends shelf life. The pharmaceutical sector represents the fastest‑growing segment due to increasing utilization in mRNA vaccine stabilization and protein‑based therapeutics. However, production cost challenges persist, with manufacturing expenses remaining 3‑4 times higher than conventional sweeteners due to complex enzymatic conversion processes. Asia‑Pacific continues to dominate production with over 75% market share, while North American demand is growing at 8.2% annually as clean‑label trends accelerate.

Trehalose Market – View in Detailed Research Report

TOP 10 TREHALOSE COMPANIES (2026)

1️⃣ Hayashibara Co., Ltd.

Headquarters: Okayama, Japan
Key Offering: Food‑grade, pharmaceutical‑grade, and cosmetic‑grade trehalose via proprietary enzymatic conversion.

Hayashibara’s century‑old expertise and vertically integrated production chain deliver trehalose at a scale unmatched by competitors. The company’s focus on process optimisation has yielded a 30% reduction in enzyme consumption, lowering unit costs and expanding market reach.

Sustainability & Growth Initiatives:

• Investment in low‑water footprint fermentation units.
• Partnerships with vaccine developers to secure long‑term supply contracts.
• Expansion of a dedicated pharmaceutical‑grade facility in 2025 to meet rising demand.

2️⃣ Meihua Holdings Group Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Bulk food trehalose and specialty trehalose for nutraceuticals.

Meihua’s aggressive capacity build‑out has positioned it as a key supplier for the rapidly expanding Chinese food‑processing sector. The company leverages a regional starch supply chain to maintain competitive pricing.

Sustainability & Growth Initiatives:

• Adoption of renewable energy sources across production sites.
• Collaboration with local governments to support rural starch cultivation.
• Development of a next‑generation enzyme consortium to further cut costs.

3️⃣ Lianmeng Chemical Group

Headquarters: Guangzhou, China
Key Offering: Specialty trehalose for pharmaceutical stabilisation.

Lianmeng’s focus on high‑purity grades aligns with the stringent requirements of biologics manufacturers, driving adoption in mRNA vaccine formulations.

Sustainability & Growth Initiatives:

• Implementation of closed‑loop water recycling in its plants.
• Strategic alliance with a global vaccine producer for joint R&D.
• Targeted expansion into Southeast Asian markets.

4️⃣ Shandong Fuyang Biotechnology Co., Ltd.

Headquarters: Shandong, China
Key Offering: Pharmaceutical‑grade trehalose for biologics and cryopreservation.

Fuyang’s niche focus on pharmaceutical‑grade trehalose has carved out a significant share in the growing biopharma segment, especially in cryoprotective applications for cell therapy.

Sustainability & Growth Initiatives:

• Integration of green chemistry principles in enzyme production.
• Partnerships with biotech firms to co‑develop advanced stabilisers.
• Expansion of a dedicated cryopreservation line in 2024.

5️⃣ Sinozyme Biotechnology Co., Ltd.

Headquarters: Wuhan, China
Key Offering: Enzyme‑based trehalose production with a focus on yield optimisation.

Sinozyme’s proprietary enzyme platform has reduced production times by 25%, positioning it as a cost leader in the pharmaceutical segment.

Sustainability & Growth Initiatives:

• Investment in bio‑refining of waste starch streams.
• Collaboration with universities for enzyme research.
• Scaling up of a high‑yield plant in 2025.

6️⃣ Jiangsu OGO Biotech Co., Ltd.

Headquarters: Nanjing, China
Key Offering: Innovative fermentation techniques for cost‑effective trehalose.

OGO’s novel fermentation process has lowered enzyme usage by 15%, enabling competitive pricing for food‑grade trehalose.

Sustainability & Growth Initiatives:

• Use of renewable biogas for process heating.
• Strategic partnership with a leading snack manufacturer.
• Expansion of a new plant in 2024 to meet Asian demand.

7️⃣ Baolingbao Biology Co., Ltd.

Headquarters: Chengdu, China
Key Offering: Research‑grade trehalose for biotechnology applications.

Baolingbao’s high‑purity trehalose supports academic and industrial research in cryopreservation and protein stability.

Sustainability & Growth Initiatives:

• Implementation of zero‑waste policies in production.
• Collaboration with global biotech labs for joint projects.
• Investment in a new high‑purity facility in 2026.

8️⃣ K-Bio Co., Ltd.

Headquarters: Osaka, Japan
Key Offering: Food‑grade trehalose for confectionery and functional beverages.

K‑Bio’s focus on clean‑label ingredients has positioned it as a preferred supplier for premium Japanese confectionery brands.

Sustainability & Growth Initiatives:

• Use of recycled packaging materials.
• Partnership with local farmers to source sustainable starch.
• Expansion of a new plant in 2025 to serve the Asia‑Pacific market.

9️⃣ Cuiyang Biotech Co., Ltd.

Headquarters: Sichuan, China
Key Offering: Pharmaceutical‑grade trehalose for vaccine stabilisation.

Cuiyang’s high‑purity trehalose is used in several emerging mRNA vaccine candidates, driving its growth in the biopharma sector.

Sustainability & Growth Initiatives:

• Adoption of low‑energy fermentation processes.
• Collaboration with a leading vaccine manufacturer.
• Expansion of a dedicated facility in 2026.

🔟 GSK Biotech Ltd.

Headquarters: London, United Kingdom
Key Offering: Pharmaceutical‑grade trehalose for biologics and cryopreservation.

GSK Biotech’s global reach and strong R&D pipeline position it as a key player in the European trehalose market.

Sustainability & Growth Initiatives:

• Investment in carbon‑neutral production facilities.
• Partnership with EU‑based vaccine developers.
• Strategic expansion into the North American market.

Download FREE Sample Report

Get Full Report

Market Outlook

Looking ahead, the trehalose market is expected to maintain a steady expansion trajectory as both the food and pharmaceutical sectors continue to demand functional ingredients that deliver stability and clean‑label credentials. The increasing focus on mRNA vaccine production and the rising prevalence of protein‑based therapeutics will sustain pressure on the pharmaceutical segment, while consumer preference for low‑glycemic sweeteners will reinforce demand in the food sector.

Future Trends

Key innovation pathways include the development of high‑purity trehalose for advanced biologics, the integration of sustainable fermentation practices, and the exploration of trehalose in cosmetic formulations that emphasize skin hydration and anti‑aging benefits. The convergence of cryopreservation technology with stem‑cell therapies also presents a compelling opportunity for trehalose to become a cornerstone ingredient in regenerative medicine.